Promethazine and Narcotic abuse - a phase IV clinical study of FDA data
Narcotic abuse is found among people who take Promethazine, especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Promethazine and have Narcotic abuse. It is created by eHealthMe based on reports of 23,114 people who have side effects when taking Promethazine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
23,114 people reported to have side effects when taking Promethazine.
Among them, 504 people (2.18%) have Narcotic abuse.
What is Promethazine?
Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 24,072 Promethazine users for its effectiveness, alternative drugs and more.
What is Narcotic abuse?
Narcotic abuse (addiction of narcotic (pain killer )) is found to be associated with 2,097 drugs and 1,617 conditions by eHealthMe.
Number of Promethazine and Narcotic abuse reports submitted per year:
Time on Promethazine when people have Narcotic abuse *:
Gender of people who have Narcotic abuse when taking Promethazine*:
Age of people who have Narcotic abuse when taking Promethazine *:
Common drugs people take besides Promethazine *:
Common side effects people have besides Narcotic abuse *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Promethazine and have Narcotic abuse?Check whether Narcotic abuse is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How severe was Narcotic abuse and when was it recovered:
Expand to all the drugs that have ingredients of promethazine hydrochloride:
Alternative drugs to, pros and cons of Promethazine:
- Promethazine (24,072 reports)
Common Promethazine side effects:
Browse all side effects of Promethazine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Narcotic abuse treatments and more:
- Narcotic abuse (72,172 reports)
COVID vaccines that are related to Narcotic abuse:
- Narcotic abuse in Moderna COVID Vaccine
- Narcotic abuse in Pfizer BioNTech Covid Vaccine
- Narcotic abuse in Johnson and Johnson Covid Vaccine
Common drugs associated with Narcotic abuse:
All the drugs that are associated with Narcotic abuse:
- Narcotic abuse (2,097 drugs)
Common conditions associated with Narcotic abuse:
All the conditions that are associated with Narcotic abuse:
- Narcotic abuse (1,617 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on promethazine hydrochloride (the active ingredients of Promethazine) and Promethazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamins and Retinopathy Of Prematurity - 3 seconds ago
- Clopra and Praxbind drug interaction - 4 seconds ago
- Imuran and Ginkgo Biloba drug interaction - 10 seconds ago
- Ms Contin and Viral Infection - 12 seconds ago
- Xylometazoline Hydrochloride and Calcitriol drug interaction - 24 seconds ago
- Lopurin and Fainting - 45 seconds ago
- Nitroglycerin and Oesophageal Irritation - 57 seconds ago
- Methergine and Vision Blurred - a minute ago
- Sulfatrim and Q10 drug interaction - a minute ago
- Clonidine Hydrochloride and Yohimbine drug interaction - a minute ago